Effects of anti-CD18 monoclonal antibody, R15.7, on the cardiopulmonary manifestations of group B streptococcal sepsis in piglets

Jack W. Bandel, Ronald N. Goldberg, Cleide Suguihara, Ren Nagoshi, Octavio V. Martinez, Robert Rothlein, Phillip Ruiz, Eduardo Bancalari

Research output: Contribution to journalArticle

Abstract

We hypothesized that anti-CD18 monoclonal antibody, R15.7, a murine IgG1 antibody which blocks leukocyte-endothelial cell adherence, might ameliorate the cardiopulmonary manifestations of sepsis secondary to group B streptococci (GBS). Twenty-six anesthetized, mechanically ventilated newborn piglets received a continuous infusion of GBS (7.5 x 109 cfu/kg/min) and were randomly assigned to a treatment group receiving R15.7 (1 mg/kg i.v.) 15 min prior to GBS infusion or to a control group. Cardiopulmonary measurements, arterial blood gases and peripheral blood leukocytes were obtained over 120 min of R15.7 infusion. GBS infusion caused significant increases in pulmonary artery and systemic arterial blood (Psa) pressures, pulmonary vascular (PVR) and systemic vascular (SVR) resistances, and PVR/SVR ratio with decreases in cardiac output and stroke volume. R15.7-treated piglets maintained significantly higher Psa (p < 0.003), dynamic lung compliance (p < 0.04), PaO2 and pH (p < 0.05), and lower total lung resistance (p < 0.01) and PaCO2 (p < 0.04). A longer median survival time was observed in the treatment group (p < 0.01). These data suggest that administration of a CD18-blocking agent prolongs survival in a young animal model of GBS sepsis, possibly secondary to improved tissue perfusion, lung mechanics and acid-base status. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish
Pages (from-to)121-128
Number of pages8
JournalBiology of the Neonate
Volume78
Issue number2
StatePublished - Aug 1 2000
Externally publishedYes

Fingerprint

Streptococcus agalactiae
Sepsis
Monoclonal Antibodies
Blood Vessels
Lung
Leukocytes
Lung Compliance
Cardiac Volume
Mechanics
Cardiac Output
Vascular Resistance
Stroke Volume
Pulmonary Artery
Arterial Pressure
Endothelial Cells
Animal Models
Perfusion
Immunoglobulin G
Gases
Control Groups

Keywords

  • Adhesion molecules
  • Group B streptococci
  • Integrins
  • Pulmonary hypertension
  • Pulmonary mechanics
  • Septic shock

ASJC Scopus subject areas

  • Developmental Biology
  • Pediatrics, Perinatology, and Child Health

Cite this

Effects of anti-CD18 monoclonal antibody, R15.7, on the cardiopulmonary manifestations of group B streptococcal sepsis in piglets. / Bandel, Jack W.; Goldberg, Ronald N.; Suguihara, Cleide; Nagoshi, Ren; Martinez, Octavio V.; Rothlein, Robert; Ruiz, Phillip; Bancalari, Eduardo.

In: Biology of the Neonate, Vol. 78, No. 2, 01.08.2000, p. 121-128.

Research output: Contribution to journalArticle

@article{3efbb512faaa467bbfa7abdad8c74648,
title = "Effects of anti-CD18 monoclonal antibody, R15.7, on the cardiopulmonary manifestations of group B streptococcal sepsis in piglets",
abstract = "We hypothesized that anti-CD18 monoclonal antibody, R15.7, a murine IgG1 antibody which blocks leukocyte-endothelial cell adherence, might ameliorate the cardiopulmonary manifestations of sepsis secondary to group B streptococci (GBS). Twenty-six anesthetized, mechanically ventilated newborn piglets received a continuous infusion of GBS (7.5 x 109 cfu/kg/min) and were randomly assigned to a treatment group receiving R15.7 (1 mg/kg i.v.) 15 min prior to GBS infusion or to a control group. Cardiopulmonary measurements, arterial blood gases and peripheral blood leukocytes were obtained over 120 min of R15.7 infusion. GBS infusion caused significant increases in pulmonary artery and systemic arterial blood (Psa) pressures, pulmonary vascular (PVR) and systemic vascular (SVR) resistances, and PVR/SVR ratio with decreases in cardiac output and stroke volume. R15.7-treated piglets maintained significantly higher Psa (p < 0.003), dynamic lung compliance (p < 0.04), PaO2 and pH (p < 0.05), and lower total lung resistance (p < 0.01) and PaCO2 (p < 0.04). A longer median survival time was observed in the treatment group (p < 0.01). These data suggest that administration of a CD18-blocking agent prolongs survival in a young animal model of GBS sepsis, possibly secondary to improved tissue perfusion, lung mechanics and acid-base status. Copyright (C) 2000 S. Karger AG, Basel.",
keywords = "Adhesion molecules, Group B streptococci, Integrins, Pulmonary hypertension, Pulmonary mechanics, Septic shock",
author = "Bandel, {Jack W.} and Goldberg, {Ronald N.} and Cleide Suguihara and Ren Nagoshi and Martinez, {Octavio V.} and Robert Rothlein and Phillip Ruiz and Eduardo Bancalari",
year = "2000",
month = "8",
day = "1",
language = "English",
volume = "78",
pages = "121--128",
journal = "Neonatology",
issn = "1661-7800",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Effects of anti-CD18 monoclonal antibody, R15.7, on the cardiopulmonary manifestations of group B streptococcal sepsis in piglets

AU - Bandel, Jack W.

AU - Goldberg, Ronald N.

AU - Suguihara, Cleide

AU - Nagoshi, Ren

AU - Martinez, Octavio V.

AU - Rothlein, Robert

AU - Ruiz, Phillip

AU - Bancalari, Eduardo

PY - 2000/8/1

Y1 - 2000/8/1

N2 - We hypothesized that anti-CD18 monoclonal antibody, R15.7, a murine IgG1 antibody which blocks leukocyte-endothelial cell adherence, might ameliorate the cardiopulmonary manifestations of sepsis secondary to group B streptococci (GBS). Twenty-six anesthetized, mechanically ventilated newborn piglets received a continuous infusion of GBS (7.5 x 109 cfu/kg/min) and were randomly assigned to a treatment group receiving R15.7 (1 mg/kg i.v.) 15 min prior to GBS infusion or to a control group. Cardiopulmonary measurements, arterial blood gases and peripheral blood leukocytes were obtained over 120 min of R15.7 infusion. GBS infusion caused significant increases in pulmonary artery and systemic arterial blood (Psa) pressures, pulmonary vascular (PVR) and systemic vascular (SVR) resistances, and PVR/SVR ratio with decreases in cardiac output and stroke volume. R15.7-treated piglets maintained significantly higher Psa (p < 0.003), dynamic lung compliance (p < 0.04), PaO2 and pH (p < 0.05), and lower total lung resistance (p < 0.01) and PaCO2 (p < 0.04). A longer median survival time was observed in the treatment group (p < 0.01). These data suggest that administration of a CD18-blocking agent prolongs survival in a young animal model of GBS sepsis, possibly secondary to improved tissue perfusion, lung mechanics and acid-base status. Copyright (C) 2000 S. Karger AG, Basel.

AB - We hypothesized that anti-CD18 monoclonal antibody, R15.7, a murine IgG1 antibody which blocks leukocyte-endothelial cell adherence, might ameliorate the cardiopulmonary manifestations of sepsis secondary to group B streptococci (GBS). Twenty-six anesthetized, mechanically ventilated newborn piglets received a continuous infusion of GBS (7.5 x 109 cfu/kg/min) and were randomly assigned to a treatment group receiving R15.7 (1 mg/kg i.v.) 15 min prior to GBS infusion or to a control group. Cardiopulmonary measurements, arterial blood gases and peripheral blood leukocytes were obtained over 120 min of R15.7 infusion. GBS infusion caused significant increases in pulmonary artery and systemic arterial blood (Psa) pressures, pulmonary vascular (PVR) and systemic vascular (SVR) resistances, and PVR/SVR ratio with decreases in cardiac output and stroke volume. R15.7-treated piglets maintained significantly higher Psa (p < 0.003), dynamic lung compliance (p < 0.04), PaO2 and pH (p < 0.05), and lower total lung resistance (p < 0.01) and PaCO2 (p < 0.04). A longer median survival time was observed in the treatment group (p < 0.01). These data suggest that administration of a CD18-blocking agent prolongs survival in a young animal model of GBS sepsis, possibly secondary to improved tissue perfusion, lung mechanics and acid-base status. Copyright (C) 2000 S. Karger AG, Basel.

KW - Adhesion molecules

KW - Group B streptococci

KW - Integrins

KW - Pulmonary hypertension

KW - Pulmonary mechanics

KW - Septic shock

UR - http://www.scopus.com/inward/record.url?scp=0033813706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033813706&partnerID=8YFLogxK

M3 - Article

C2 - 10971005

AN - SCOPUS:0033813706

VL - 78

SP - 121

EP - 128

JO - Neonatology

JF - Neonatology

SN - 1661-7800

IS - 2

ER -